| Univariate linear regression | Multivariable linear regression | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Reservoir strain | Conduit strain | Booster strain | Reservoir strain | Conduit strain | Booster strain | ||||||
 | β | P values | β | P values | β | P values | β | P values | β | P values | β | P values |
Age, per year |  − 0.11 |  < 0.001* |  − 0.19 |  < 0.001* | 0.06 |  < 0.001* |  − 0.10 |  < 0.001* |  − 0.18 |  < 0.001* | 0.04 | 0.018* |
Gender | 1.17 | 0.102 | 1.45 | 0.050 | 0.66 | 0.196 | – | – | – | – | – | – |
Systolic blood pressure, per mmHg |  − 0.06 | 0.001* |  − 0.07 |  < 0.001* | 0.01 | 0.567 | 0.01 | 0.637 |  − 0.01 | 0.891 | – | – |
Diastolic blood pressure, per mmHg |  − 0.07 | 0.027* |  − 0.07 | 0.052 |  − 0.01 | 0.599 |  − 0.04 | 0.309 | – | – | – | – |
Body mass index, per unit |  − 0.10 | 0.120 |  − 0.16 | 0.024* | 0.06 | 0.245 | – | – | 0.11 | 0.095 | – | – |
Hypertension |  − 0.52 | 0.392 |  − 2.06 | 0.001* | 1.29 | 0.003* | – | – | 0.71 | 0.272 | 0.01 | 0.998 |
Diabetes | 0.07 | 0.951 |  − 2.36 | 0.044* | 2.00 | 0.014* | – | – |  − 0.21 | 0.834 | 0.65 | 0.473 |
Smoking history | 0.31 | 0.655 |  − 1.38 | 0.056 | 1.59 | 0.001* | – | – | – | – | 1.33 | 0.014* |
Hypercholesterolemia |  − 0.46 | 0.626 |  − 2.20 | 0.024* | 1.24 | 0.066 | – | – |  − 0.21 | 0.771 | – | – |
Familyhistory of SCD 1st degree relative | 0.67 | 0.566 | 0.24 | 0.843 | 0.68 | 0.424 | – | – | – | – | – | – |
Family history of SCD 2nd degree relative | 0.56 | 0.540 | 0.26 | 0.786 | 0.34 | 0.613 | – | – | – | – | – | – |
SCD risk score |  − 0.24 | 0.602 |  − 0.85 | 0.067 | 0.56 | 0.080 | – | – | – | – | – | – |
VT | 0.17 | 0.864 |  − 1.19 | 0.257 | 1.49 | 0.038* | – | – | – | – | 1.24 | 0.093 |
TIA stroke |  − 1.83 | 0.461 |  − 1.98 | 0.442 |  − 0.17 | 0.923 | – | – | – | – | – | – |
Syncope |  − 1.40 | 0.088 |  − 2.34 | 0.006* | 0.60 | 0.313 | – | – |  − 0.70 | 0.376 | – | – |
NYHA class |  − 1.84 |  < 0.001* |  − 2.63 |  < 0.001* | 0.35 | 0.325 |  − 1.07 | 0.042* |  − 0.52 | 0.274 | – | – |
LGE, presence/absence |  − 2.15 | 0.012* |  − 3.88 |  < 0.001* | 1.33 | 0.030* |  − 0.93 | 0.256 |  − 1.86 | 0.007* | 0.71 | 0.254 |
LGE, % | 0.02 | 0.561 |  − 0.05 | 0.123 | 0.05 | 0.028* | – | – | – | – | 0.02 | 0.368 |
LGE mass, grams |  − 0.03 | 0.166 |  − 0.05 | 0.017* | 0.01 | 0.409 | – | – |  − 0.02 | 0.186 | – | – |
Presence of sarcomeric variant | 0.88 | 0.166 | 2.49 |  < 0.001* |  − 1.37 | 0.002* | – | – | 0.24 | 0.722 |  − 0.72 | 0.215 |
Mitral regurgitation |  − 3.26 | 0.001* |  − 4.12 |  < 0.001* | 0.16 | 0.816 |  − 1.16 | 0.256 |  − 2.89 | 0.001* | – | – |
LV maximal wall thickness, mm |  − 0.32 |  < 0.001* |  − 0.32 |  < 0.001* |  − 0.05 | 0.386 |  − 0.20 | 0.021* |  − 0.15 | 0.052 | – | – |
LV mass, grams |  − 0.03 |  < 0.001* |  − 0.02 | 0.003* |  − 0.01 | 0.068 |  − 0.01 | 0.035* |  − 0.01 | 0.030* | – | – |
LVOT max pressure gradient, mmHg | 0.08 | 0.462 |  − 0.12 | 0.282 | 0.13 | 0.101 | – | – | – | – | – | – |
LVOT obstruction ≥ 30 mmHg, n, % |  − 0.88 | 0.271 |  − 1.01 | 0.223 |  − 0.23 | 0.693 | – | – | – | – | – | – |
LVEDV index, mL/m2 | 0.02 | 0.383 | 0.06 | 0.003* |  − 0.03 | 0.028* | – | – |  − 0.04 | 0.278 |  − 0.02 | 0.370 |
LVESV index, mL/m2 |  − 0.03 | 0.385 | 0.03 | 0.452 |  − 0.05 | 0.088 | – | – | – | – | – | – |
LV stroke volume index, mL/m2 | 0.06 | 0.050 | 0.12 |  < 0.001* |  − 0.04 | 0.055 | – | – | 0.13 | 0.011* | – | – |
LV ejection Fraction, % | 0.10 | 0.024* | 0.08 | 0.076 | 0.02 | 0.589 | 0.131 | 0.002* | – | – | – | – |